诺和诺德即将推出革命性减肥疗法CagriSema! 据媒体报道,诺德诺德为了保持在减肥药市场的领先地位,正在转向研发新款GLP-1类药物,该产品名为CagriSema,预计至少能实现25%的减重效果,较上一代减肥药Wegovy而言不会带来额外副作用。 诺和诺德表示,CagriSema将有效解决“停药后体重反弹”的问题,成为迄今为止最有效的减肥药,其针对二型糖尿病的疗效仍在探索中。 全新减肥疗法将至...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.